Substance abuse refers to the use of psychoactive substances, which include alcohol and illicit drugs, to the extent that it is harmful or hazardous. Psychoactive substance abuse can lead to dependence syndrome - a cluster of behavioral, physiological, and cognitive symptoms stemming from the body’s reaction to a lack of the respective substance. This develops as a result of continual use of the substance and typically involve a strong urge to take the drug, difficulty to control the use of the drug, persistent use of the drug despite harmful effects, and higher priority to drug use over other activities and obligations.

Browse Full Report With TOC:-http://www.transparencymarketresearch.com/substance-abuse-treatment-market.html

The reasons for substance abuse are many - chaotic domestic environment, poor social skills, and genetic risks are some of the reasons that lead to substance abuse. Aggressive behavior, irritability, and forgetfulness are some of the symptoms indicative of substance abuse. Early recognition of symptoms related with substance abuse leads to a higher chance of successful treatment. The global substance abuse treatment market is segmented into alcohol, drug abuse therapeutics, and nicotine dependence therapeutics.

Substance Abuse Treatment Works Best in Combination with other Support Therapies

A large number of studies carried out for substance abuse treatment support the notion that a combination of behavioral therapy/counselling and medications is the best-suited mode for treating patients. This is needed, as long-term use of drugs changes brain function so as to make resisting the urge to use the drugs a harder choice. Thus, prevention of relapse is one of the most important aspects of substance abuse treatment.

The substance abuse treatment market is primarily driven by factors such as increased awareness and financial assistance for mental well-being in long-term substance abuse treatment. In addition, the increasing prevalence of substance abuse illnesses due to physical, social, and economic reasons is contributing to the growth of this market. This, in turn, is boosting the number of mental and substance abuse centers.

Other factors such as the high annual treatment cost and regulatory mandates for substance abuse treatment affect the growth of this market negatively and positively, respectively. The latter could negate the influence of the former in the long run, making substance abuse treatment affordable for all and boosting the global market for the same. Factors such as the lack of willingness to seek treatment slow the growth of this market.

Complementary Medication Necessary to Treat Drug Abuse Effectively

Zyban and Chantix (vareniciline) are some of the medications used against nicotine addiction. In addition, drugs such as Campral (acamprosate calcium), Disulfrum, and Vivitrol (naltrexone) are recommended for patients suffering from alcohol dependency. Some of the commonly used drugs against which drug abuse treatment is applied are cocaine and opioids.The prescription drugs for a specific substance abuse condition are complemented with certain medications that help resist the urge and manage secondary medical conditions resulting from substance abuse. For example, methadone and nicotine patches help control drug cravings and withdrawal symptoms. As a part of substance abuse treatment, patients are advised to seek immediate medical help in the event of an unexpected deviation in mental and physical health. Along with this, behavioral therapy is an important component of substance abuse treatment. This helps patients resist the urge for use of drugs and avoid relapse. Some of the major companies operating in the global substance abuse treatment market are Teva Pharmaceutical Industries Ltd., Alkermes Plc, Pfizer Inc., GlaxoSmithkline Plc, and Reckitt Benckiser Pharmaceuticals Inc.

Request Brochure:-http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4067